They both repress hypoxia-inducible factor-1α (HIF-1α) and disturb intracellular redox homeostasis in CLL cells, as well as highly active against protected primary CLL cells [154, 155]. This evidence concerns the gene HIF1A and B-cell chronic lymphocytic leukemia.